Abeona Therapeutics ABEO
NASDAQ ABEO
$2.60 +0.18 (+7.44%)
At close: Nov 16, 2026 · 4:00 PM EST

Abeona Therapeutics (ABEO) Research & Development (2009 - 2026)

Updated

Abeona Therapeutics (ABEO) posted Research & Development of $3.67 million for Q3 2026, down 12.9% from $4.22 million a year earlier and down 26.9% from the prior quarter.

Analysis

Abeona Therapeutics (ABEO) Research & Development (2009 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Research & Development at Abeona Therapeutics was $24.96 million, down 14.2% year-over-year; for FY2025, it came in at $26.81 million, down 22.0% from FY2024.

  • Annual Research & Development shows a five-year compound annual growth rate of -2.3% (FY2020 to FY2025).
  • In prior years, Abeona Therapeutics' Research & Development was $34.36 million in FY2024 (+10.5%), $31.09 million in FY2023 (+7.3%), $28.97 million in FY2022 (-25.2%) and $38.73 million in FY2021 (+28.5%).
  • The Q3 2026 figure stands as the lowest quarterly Research & Development since Q3 2017.
  • On a year-over-year basis, Research & Development has declined in each of the last six quarters, with an average decline of 10.8% over the last eight quarters.
  • The strongest year-over-year quarter for Research & Development in the past five years was Q4 2021, with growth of 38.5%; the weakest was Q3 2025, with a decline of 52.8%.
  • According to Business Quant data, Research & Development for the three prior quarters was $5.02 million (Q2 2026), $9.56 million (Q1 2026) and $6.71 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 4.25 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 4.65 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 2.57 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 4.54 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 3.89 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 2.11 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 1.61 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 3.02 Bn
10 Abeona Therapeutics 149.28 Mn -492.16 Mn 7.78 Mn 3.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.67 Mn
Jun 30, 2026 5.02 Mn
Mar 31, 2026 9.56 Mn
Dec 31, 2025 6.71 Mn
Sep 30, 2025 4.22 Mn
Jun 30, 2025 5.94 Mn
Mar 31, 2025 9.94 Mn
Dec 31, 2024 8.99 Mn
Sep 30, 2024 8.94 Mn
Jun 30, 2024 9.22 Mn
Mar 31, 2024 7.21 Mn
Dec 31, 2023 7.38 Mn
Sep 30, 2023 7.15 Mn
Jun 30, 2023 8.52 Mn
Mar 31, 2023 8.04 Mn
Dec 31, 2022 6.27 Mn
Sep 30, 2022 5.49 Mn
Jun 30, 2022 6.66 Mn
Mar 31, 2022 10.55 Mn
Dec 31, 2021 12.80 Mn
API Access

Abeona Therapeutics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=ABEO&period=max&api_key=YOUR_API_KEY